Further Research

 
News Articles for Further Research top ^
2014/5/16
In the first and fifth paragraphs of release dated May 15, 2014, the amount of the additional distribution should read: $0.8489 per Debenture (instead of $1.0800 per Debenture). The corrected release reads: LIBERTY ANNOUNCES SEMI-ANNUAL PAYMENT ON 4.0% SENIOR EXCHANGEABLE DEBENTURES DUE 2029 - RESULTS IN FURTHER REDUCTION OF ADJUSTED PRINCIPAL AMOUNT Liberty Interactive LLC ("Liberty"), a subsidiary of Liberty Interactive Corporation (Nasdaq: LINTA, LINTB, LVNTA, LVNTB), announces a semi-annual payment and additional distribution to the holders of its 4.0% Senior Exchangeable Debentures due 2029 (the "Debentures"). The amount of the payment is $20.00 per $1,000 original principal amount of Debentures, and the amount of the additional distribution is $0.8489 per Debenture.
Sign-up for CORRECTING and REPLACING Liberty Announces Semi-Annual Payment on 4.0% Senior Exchangeable Debentures Due 2029 - Results in Further Reduction of Adjusted Principal Amount investment picks
The Mantle-Cell and Follicular Lymphoma Tests Were Validated In Research Collaborations With Memorial Sloan Kettering and Have Been Successfully Licensed Under Both CLIA and New York State Regulations Tests Address Over One-Third of non-Hodgkin Lymphomas And Will Be Made Available As Part of Comprehensive Testing Programs To Provide Targeted Diagnostic And Prognostic Information RUTHERFORD, N.J., May 5, 2014 (GLOBE NEWSWIRE) -- Cancer Genetics, Inc. (Nasdaq:CGIX) ("CGI" or the "Company"), an emerging leader in DNA-based diagnostics, today announced it has received CLIA and New York state approvals for clinical use of its proprietary mature B-cell neoplasm array, or MatBA ® for Follicular Lymphoma (MatBA ® -FL) and Mantle-Cell Lymphoma (MatBA ® -MCL). Both tests further extend the portfolio in hematologic cancers being developed by CGI and both were developed and validated via a research collaboration with Memorial Sloan-Kettering Cancer Center.
Sign-up for Cancer Genetics Launches Genomic Tests for Follicular Lymphoma and Mantle Cell Lymphoma - Further Extends Unique Position in Targeted Testing of Hematologic Cancers investment picks
http://media.marketwire.com/attachments/201405/TN-248595_newwaveprepaid.jpg http://media.marketwire.com/attachments/201401/216771_adcslogo.jpg http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1115202&ProfileId=051205&sourceType=1 LAS VEGAS, NV --
Sign-up for Advanced Content Services, Inc. Announces Shareholder Update on Joint Venture LOI and Reinstatement in Nevada; Further Reduces Liabilities by $78,000 investment picks
2014/5/15
Landis+Gyr has signed an agreement to purchase PowerSense, a Danish smart grid sensor and monitoring company with global reach to give utilities optimum distribution grid management options ZUG, Switzerland , May 15, 2014 /PRNewswire/ -- Landis+Gyr, the global leader in energy management solutions, today announced that it has acquired PowerSense, a global player in smart grid technologies, and will integrate it into its portfolio.
Sign-up for Landis+Gyr to Further Enable Utilities with Acquisition of PowerSense investment picks
2014/5/19
By Laura He, MarketWatch HONG KONG (MarketWatch) -- China's property prices are showing further signs of a slowdown amid government curbs, with Beijing's prices for second-home purchases falling in April by the most in two years, while newly built residential housing price gains eased for the sixth straight month.
Sign-up for UPDATE: China real-estate market cools further investment picks
2014/5/19
By Laura He, MarketWatch HONG KONG (MarketWatch) -- China's property prices are showing further signs of a slowdown amid government curbs, with Beijing's prices for second-home purchases falling in April by the most in two years, while newly built residential housing price gains eased for the sixth straight month.
Sign-up for UPDATE: China property market cools further investment picks
By Laura He, MarketWatch HONG KONG (MarketWatch) -- China's property prices are showing further signs of a slowdown amid government curbs, with Beijing's prices for second-home purchases falling in April by the most in two years, while newly built non-government residential housing price gains eased for the sixth straight month.
Sign-up for China property market cools further investment picks

Premium Membership: Features and Benefits
Wide-Moat Screener for Stocks

Put a moat around your portfolio. Sniff out the most promising opportunities that can ride through any market.

Gold Medalist Screener for Funds

Narrow the available universe of 5000 funds to the top rated gold and silver. Then, sort for manager tenure, expense ratio, risk and return to create your own index-beating fund watchlist.

Thousands of Premium Analyst Reports

While many of our competitors measure a stock's worth with a computer program, Morningstar's staff of 150+ analyst sift through company fillings, financial data and a wealth of other sources to deliver an unvarnished review of any investment. In fact, twelve Morningstar analysts have been recognized by WSJ as "Best on the Street" in the US.

Premium Portfolio Monitor

Make decisions with confidence. Load your investments into our research center and automatically connect to all our proprietary tools and data points.

Mobile

Never be without critical research. Free with your active membership, take our Premium data and guidance wherever you go with Morningstar for iPad®, iPhone®, and Android apps.

Morningstar's Guarantee

We're looking out for you. If after your 14-day free trial, you find that a Morningstar Premium membership is not for you, cancel any time and we'll be happy to refund the unused portion - no questions asked.

Go Premium!
Exclusive Premium Member Benefits
Get the best thinking of 150+ disciplined
objective, experienced analysts-dedicated to
specific industries and securities.
+2,500 Analyst Reports
Wide Moat Screener for Stocks
Medalist Screener for Funds
Premium Portfolio Manager with X-Ray & Monitor
Premium eNewsletters
Morningstar Basic Benefits (All)
Sign up now - No charge for the first 14 days
Further Research
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Title |  Date |  Author |  Collection |  Interest |  Popularity Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry |  Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry

Previous: Furniture Industry  |  Next: Future Developments